ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 46 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $52,147 | -98.3% | 48,000 | -98.4% | 0.00% | -100.0% |
Q3 2020 | $3,065,000 | -9.2% | 2,935,000 | -3.8% | 0.03% | -15.0% |
Q2 2020 | $3,377,000 | -14.3% | 3,051,000 | -20.9% | 0.04% | -9.1% |
Q1 2020 | $3,942,000 | +1278.3% | 3,859,000 | +1431.3% | 0.04% | +2100.0% |
Q4 2019 | $286,000 | -87.9% | 252,000 | -87.8% | 0.00% | -88.9% |
Q3 2019 | $2,361,000 | -55.1% | 2,069,000 | -53.3% | 0.02% | -52.6% |
Q2 2019 | $5,264,000 | +79.9% | 4,427,000 | +104.7% | 0.04% | +58.3% |
Q1 2019 | $2,926,000 | +85.9% | 2,163,000 | +45.7% | 0.02% | +140.0% |
Q3 2018 | $1,574,000 | -46.5% | 1,485,000 | -50.5% | 0.01% | -37.5% |
Q2 2018 | $2,943,000 | +506.8% | 3,003,000 | +512.9% | 0.02% | +433.3% |
Q1 2018 | $485,000 | -76.4% | 490,000 | -75.6% | 0.00% | -72.7% |
Q4 2016 | $2,051,000 | +196.4% | 2,012,000 | +106.4% | 0.01% | +266.7% |
Q2 2016 | $692,000 | -25.1% | 975,000 | +18.8% | 0.00% | -40.0% |
Q4 2015 | $924,000 | – | 821,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 83,741,000 | $95,429,000 | 6.49% |
STEELHEAD PARTNERS LLC | 52,496,000 | $59,911,000 | 5.47% |
SILVERBACK ASSET MANAGEMENT LLC | 23,000,000 | $26,278,000 | 4.02% |
Castle Creek Arbitrage, LLC | 10,734,000 | $12,253,000 | 3.09% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 40,132,000 | $45,920,000 | 2.81% |
Sonora Investment Management, LLC | 16,707,000 | $19,084,000 | 1.99% |
TFG Asset Management GP Ltd | 8,500,000 | $9,718,000 | 1.73% |
Verition Fund Management LLC | 27,901,000 | $31,890,000 | 0.88% |
SSI INVESTMENT MANAGEMENT LLC | 7,872,000 | $8,977,000 | 0.65% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,780,000 | $5,514,000 | 0.63% |